Part VI. Primary drug therapies for Alzheimer's disease.
Knopman
D S
DS
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000529:Complementary Therapies; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D018721:Muscarinic Agonists / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D002800:Cholinesterase Inhibitors; D004967:Estrogens; D018721:Muscarinic Agonists